{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:43:39Z","timestamp":1792219419974,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007753","name":"University of Eastern Finland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007753","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Anemia and iron deficiency during pregnancy have been associated with preterm birth and neonatal complications. However, the evidence on whether intravenous or oral supplementation should be used has been conflicting. The aim was to assess the effectiveness of intravenous iron compared to oral iron supplementation on objective neonatal outcomes. We conducted a systematic review and meta-analysis of randomized controlled trials. Two databases were searched in November 2024 and the search was updated in February 2025. The main outcomes were the rate of preterm birth, stillbirths, and neonatal mortality. Random-effect meta-analysis was used to calculate risk ratios (RR) with 95% confidence intervals (CI). Evidence certainty was assessed according to GRADE. A total of 375 studies were screened and finally 15 were included. Seven studies with 8431 pregnancies analyzed the risk of preterm birth, and the risk appeared to be similar in both groups (RR 0.96, CI 0.86 to 1.07; moderate certainty evidence). Five studies with 8639 pregnancies analyzed the risk of stillbirth and found no difference (RR 0.85, CI 0.64 to 1.13; low certainty evidence). The neonatal mortality rate was 2.0% in the intravenous iron group, and 2.3% in the oral iron group (RR 0.90, CI 0.66 to 1.22; low certainty evidence). Cord hemoglobin levels were comparable between the study groups (mean difference 0.05\u00a0g\/l, CI \u22120.33 to 0.24; low certainty evidence), and ferritin levels were slightly higher in the intravenous group (mean difference 19\u00a0\u00b5g\/l, CI 0.5 to 38; low certainty evidence).\n                    <jats:italic>Conclusions<\/jats:italic>\n                    : Neonatal clinical outcomes did not differ between intravenous and oral iron supplementation treatment in pregnancy. A higher ferritin level in umbilical cord blood was found in the intravenous iron supplementation group, but the clinical relevance of this difference is unknown. Based on the results of this study, oral iron supplementation is a sufficient way to treat maternal iron deficiency, when focusing on objective neonatal outcomes.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Trial registration<\/jats:italic>\n                    : PROSPERO 2024 CRD42024615533 Available from:\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42024615533\" ext-link-type=\"uri\">https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42024615533<\/jats:ext-link>\n                    .\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td align=\"left\">\n                              <jats:bold>What is Known:<\/jats:bold>\n                              \u2022\u00a0\n                              <jats:italic>Iron-deficiency anemia during pregnancy is associated with preterm birth and neonatal complications.<\/jats:italic>\n                              \u2022\u00a0\n                              <jats:italic>Intravenous iron increases maternal hemoglobin faster than oral iron, but benefits for neonatal outcomes have been unclear.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                          <jats:tr>\n                            <jats:td align=\"left\">\n                              <jats:bold>What is New:<\/jats:bold>\n                              \u2022\u00a0\n                              <jats:italic>This systematic review and meta-analysis shows that neonatal outcomes\u2014including preterm birth, stillbirth, and mortality\u2014do not\u00a0<\/jats:italic>\n                              <jats:italic>differ between intravenous and oral iron supplementation.<\/jats:italic>\n                              \u2022\u00a0\n                              <jats:italic>Intravenous iron yields higher cord ferritin, but its clinical relevance remains uncertain.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-025-06522-w","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:36:09Z","timestamp":1760366169000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The effect of intravenous iron supplementation compared to oral iron supplementation during pregnancy on neonatal outcomes\u2014a systematic review of randomized controlled trials"],"prefix":"10.1007","volume":"184","author":[{"given":"Ilari","family":"Kuitunen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisa","family":"Veps\u00e4l\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sepp\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elli","family":"Toivonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atte","family":"Nikkil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"6522_CR1","unstructured":"The global prevalence of anaemia in 2011.  https:\/\/www.who.int\/publications\/i\/item\/9789241564960. Accessed 2  Feb 2025"},{"key":"6522_CR2","first-page":"1002","volume":"34","author":"M Auerbach","year":"2021","unstructured":"Auerbach M, Abernathy J, Juul S, Short V, Derman R (2021) Prevalence of iron deficiency in first trimester, nonanemic pregnant women. J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet 34:1002\u20131005","journal-title":"J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet"},{"key":"6522_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/nyas.14093","volume":"1450","author":"MF Young","year":"2019","unstructured":"Young MF, Oaks BM, Tandon S, Martorell R, Dewey KG, Wendt AS (2019) Maternal hemoglobin concentrations across pregnancy and maternal and child health: a systematic review and meta-analysis. Ann N Y Acad Sci 1450:47\u201368","journal-title":"Ann N Y Acad Sci"},{"key":"6522_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/AOG.0000000000004559","volume":"138","author":"AH James","year":"2021","unstructured":"James AH (2021) Iron deficiency anemia in pregnancy. Obstet Gynecol 138:663\u2013674","journal-title":"Obstet Gynecol"},{"key":"6522_CR5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ajog.2020.03.006","volume":"223","author":"MK Georgieff","year":"2020","unstructured":"Georgieff MK (2020) Iron deficiency in pregnancy. Am J Obstet Gynecol 223:516\u2013524","journal-title":"Am J Obstet Gynecol"},{"key":"6522_CR6","first-page":"CD004736","volume":"8","author":"JL Finkelstein","year":"2024","unstructured":"Finkelstein JL, Cuthbert A, Weeks J et al (2024) Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev 8:CD004736","journal-title":"Cochrane Database Syst Rev"},{"key":"6522_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1067\/mpd.2002.120688","volume":"140","author":"T Tamura","year":"2002","unstructured":"Tamura T, Goldenberg RL, Hou J et al (2002) Cord serum ferritin concentrations and mental and psychomotor development of children at five years of age. J Pediatr 140:165\u2013170","journal-title":"J Pediatr"},{"key":"6522_CR8","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/aje\/kwu208","volume":"180","author":"RJ Schmidt","year":"2014","unstructured":"Schmidt RJ, Tancredi DJ, Krakowiak P, Hansen RL, Ozonoff S (2014) Maternal intake of supplemental iron and risk of autism spectrum disorder. Am J Epidemiol 180:890\u2013900","journal-title":"Am J Epidemiol"},{"key":"6522_CR9","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.3945\/jn.112.162362","volume":"142","author":"J Shao","year":"2012","unstructured":"Shao J, Lou J, Rao R et al (2012) Maternal serum ferritin concentration is positively associated with newborn iron stores in women with low ferritin status in late pregnancy. J Nutr 142:2004\u20132009","journal-title":"J Nutr"},{"key":"6522_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0022-3476(05)82554-5","volume":"121","author":"CD Petry","year":"1992","unstructured":"Petry CD, Eaton MA, Wobken JD, Mills MM, Johnson DE, Georgieff MK (1992) Iron deficiency of liver, heart, and brain in newborn infants of diabetic mothers. J Pediatr 121:109\u2013114","journal-title":"J Pediatr"},{"key":"6522_CR11","doi-asserted-by":"publisher","first-page":"1694S","DOI":"10.3945\/ajcn.117.156075","volume":"106","author":"KG Dewey","year":"2017","unstructured":"Dewey KG, Oaks BM (2017) U-shaped curve for risk associated with maternal hemoglobin, iron status, or iron supplementation. Am J Clin Nutr 106:1694S\u20131702S","journal-title":"Am J Clin Nutr"},{"key":"6522_CR12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/bjh.16221","volume":"188","author":"S Pavord","year":"2020","unstructured":"Pavord S, Daru J, Prasannan N et al (2020) UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol 188:819\u2013830","journal-title":"Br J Haematol"},{"key":"6522_CR13","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1097\/AOG.0000000000004477","volume":"138","author":"Anemia in pregnancy","year":"2021","unstructured":"Anemia in pregnancy (2021) ACOG Practice Bulletin, Number 233. Obstet Gynecol 138:e55\u201364","journal-title":"Obstet Gynecol"},{"key":"6522_CR14","unstructured":"Centers for Disease Control and Prevention (1998) Recommendations to prevent and control iron deficiency in the United States. MMWR Recomm Rep\u00a047(RR\u20133):1\u201329"},{"key":"6522_CR15","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1001\/jama.2024.15196","volume":"332","author":"US Preventive Services Task Force","year":"2024","unstructured":"US Preventive Services Task Force (2024) Screening and supplementation for iron deficiency and iron deficiency anemia during pregnancy: US preventive services task force recommendation statement. JAMA 332:906\u2013913","journal-title":"JAMA"},{"key":"6522_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41598-023-50234-w","volume":"14","author":"AK Pandey","year":"2024","unstructured":"Pandey AK, Gautam D, Tolani H, Neogi SB (2024) Clinical outcome post treatment of anemia in pregnancy with intravenous versus oral iron therapy: a systematic review and meta-analysis. Sci Rep 14:179","journal-title":"Sci Rep"},{"key":"6522_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.5694\/mja2.50308","volume":"211","author":"A Qassim","year":"2019","unstructured":"Qassim A, Grivell RM, Henry A, Kidson-Gerber G, Shand A, Grzeskowiak LE (2019) Intravenous or oral iron for treating iron deficiency anaemia during pregnancy: systematic review and meta-analysis. Med J Aust 211:367\u2013373","journal-title":"Med J Aust"},{"key":"6522_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41372-019-0320-2","volume":"39","author":"AK Lewkowitz","year":"2019","unstructured":"Lewkowitz AK, Gupta A, Simon L et al (2019) Intravenous compared with oral iron for the treatment of iron-deficiency anemia in pregnancy: a systematic review and meta-analysis. J Perinatol 39:519\u2013532","journal-title":"J Perinatol"},{"key":"6522_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jclinepi.2020.11.003","volume":"133","author":"J Thomas","year":"2021","unstructured":"Thomas J, McDonald S, Noel-Storr A et al (2021) Machine learning reduced workload with minimal risk of missing studies: development and evaluation of a randomized controlled trial classifier for Cochrane reviews. J Clin Epidemiol 133:140\u2013151","journal-title":"J Clin Epidemiol"},{"key":"6522_CR20","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898","journal-title":"BMJ"},{"key":"6522_CR21","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924\u2013926","journal-title":"BMJ"},{"key":"6522_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jclinepi.2022.07.014","volume":"150","author":"L Zeng","year":"2022","unstructured":"Zeng L, Brignardello-Petersen R, Hultcrantz M et al (2022) Grade guidance 34: update on rating imprecision using a minimally contextualized approach. J Clin Epidemiol 150:216\u2013224","journal-title":"J Clin Epidemiol"},{"key":"6522_CR23","unstructured":"Higgins JP, Thomas J, Chandler J et al (2022) Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane. Available from  https:\/\/www.training.cochrane.org\/handbook.\u00a0Accessed 1 Feb 2025"},{"key":"6522_CR24","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/biom.12817","volume":"74","author":"L Lin","year":"2018","unstructured":"Lin L, Chu H (2018) Quantifying publication bias in meta-analysis. Biometrics 74:785\u2013794","journal-title":"Biometrics"},{"key":"6522_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM et al (2021) PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 372:n160","journal-title":"BMJ"},{"key":"6522_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1053\/j.seminhematol.2018.04.006","volume":"55","author":"AA Khalafallah","year":"2018","unstructured":"Khalafallah AA, Hyppa A, Chuang A et al (2018) A prospective randomised controlled trial of a single intravenous infusion of ferric carboxymaltose vs single intravenous iron polymaltose or daily oral ferrous sulphate in the treatment of iron deficiency anaemia in pregnancy. Semin Hematol 55:223\u2013234","journal-title":"Semin Hematol"},{"key":"6522_CR27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1365-2796.2010.02251.x","volume":"268","author":"A Khalafallah","year":"2010","unstructured":"Khalafallah A, Dennis A, Bates J et al (2010) A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. J Intern Med 268:286\u2013295","journal-title":"J Intern Med"},{"key":"6522_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s12288-012-0224-1","volume":"30","author":"A Gupta","year":"2014","unstructured":"Gupta A, Manaktala U, Rathore AM (2014) A randomised controlled trial to compare intravenous iron sucrose and oral iron in treatment of iron deficiency anemia in pregnancy. Indian J Hematol Blood Transfus 30:120\u2013125","journal-title":"Indian J Hematol Blood Transfus"},{"key":"6522_CR29","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/S0140-6736(23)00278-7","volume":"401","author":"SR Pasricha","year":"2023","unstructured":"Pasricha SR, Mwangi MN, Moya E et al (2023) Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial. Lancet 401:1595\u20131609","journal-title":"Lancet"},{"key":"6522_CR30","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1515\/jpm-2016-0050","volume":"45","author":"C Breymann","year":"2017","unstructured":"Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J (2017) Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). J Perinat Med 45:443\u2013453","journal-title":"J Perinat Med"},{"key":"6522_CR31","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1447-0756.2012.01982.x","volume":"39","author":"PK Kochhar","year":"2013","unstructured":"Kochhar PK, Kaundal A, Ghosh P (2013) Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial. J Obstet Gynaecol Res 39:504\u2013510","journal-title":"J Obstet Gynaecol Res"},{"key":"6522_CR32","doi-asserted-by":"publisher","first-page":"e1649","DOI":"10.1016\/S2214-109X(24)00239-0","volume":"12","author":"BB Afolabi","year":"2024","unstructured":"Afolabi BB, Babah OA, Adeyemo TA et al (2024) Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial. Lancet Glob Health 12:e1649\u2013e1659","journal-title":"Lancet Glob Health"},{"key":"6522_CR33","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/01.AOG.0000185260.82466.b4","volume":"106","author":"RA Al","year":"2005","unstructured":"Al RA, Unlubilgin E, Kandemir O, Yalvac S, Cakir L, Haberal A (2005) Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial. Obstet Gynecol 106:1335\u20131340","journal-title":"Obstet Gynecol"},{"key":"6522_CR34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ejogrb.2009.03.006","volume":"144","author":"G Bencaiova","year":"2009","unstructured":"Bencaiova G, von Mandach U, Zimmermann R (2009) Iron prophylaxis in pregnancy: intravenous route versus oral route. Eur J Obstet Gynecol Reprod Biol 144:135\u2013139","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"6522_CR35","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1067\/mob.2002.121894","volume":"186","author":"F Bayoumeu","year":"2002","unstructured":"Bayoumeu F, Subiran-Buisset C, Baka NE, Legagneur H, Monnier-Barbarino P, Laxenaire MC (2002) Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. Am J Obstet Gynecol 186:518\u2013522","journal-title":"Am J Obstet Gynecol"},{"key":"6522_CR36","doi-asserted-by":"publisher","first-page":"101063","DOI":"10.1016\/j.ajogmf.2023.101063","volume":"5","author":"AM Awomolo","year":"2023","unstructured":"Awomolo AM, McWhirter A, Sadler LC, Coppola LM, Hill MG (2023) Neonatal outcomes from a randomized controlled trial of maternal treatment of iron deficiency anemia with intravenous ferumoxytol vs oral ferrous sulfate. Am J Obstet Gynecol MFM 5:101063","journal-title":"Am J Obstet Gynecol MFM"},{"key":"6522_CR37","first-page":"e34858","volume":"15","author":"N Chauhan","year":"2023","unstructured":"Chauhan N, Dogra P, Sharma R, Kant S, Soni M (2023) Randomized controlled trial comparing ferrous sulfate and iron sucrose in iron deficiency anemia in pregnancy. Cureus 15:e34858","journal-title":"Cureus"},{"key":"6522_CR38","doi-asserted-by":"publisher","first-page":"e1706","DOI":"10.1016\/S2214-109X(19)30427-9","volume":"7","author":"SB Neogi","year":"2019","unstructured":"Neogi SB, Devasenapathy N, Singh R et al (2019) Safety and effectiveness of intravenous iron sucrose versus standard oral iron therapy in pregnant women with moderate-to-severe anaemia in India: a multicentre, open-label, phase 3, randomised, controlled trial. Lancet Glob Health 7:e1706\u2013e1716","journal-title":"Lancet Glob Health"},{"key":"6522_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41591-024-03385-w","volume":"31","author":"S-R Pasricha","year":"2025","unstructured":"Pasricha S-R, Moya E, Ata\u00edde R et al (2025) Ferric carboxymaltose for anemia in late pregnancy: a randomized controlled trial. Nat Med 31:197\u2013206","journal-title":"Nat Med"},{"key":"6522_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2025.01.037","author":"RJ Derman","year":"2025","unstructured":"Derman RJ, Bellad MB, Somannavar MS et al (2025) Single-dose intravenous iron vs oral iron for treatment of maternal iron deficiency anemia: a randomized clinical trial. Am J Obstet Gynecol. https:\/\/doi.org\/10.1016\/j.ajog.2025.01.037","journal-title":"Am J Obstet Gynecol"},{"key":"6522_CR41","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114524003362","author":"LX Pei","year":"2025","unstructured":"Pei LX, Hutcheon JA, Karakochuk CD (2025) An assessment of cord ferritin concentration and its predictors among a cohort of Canadian preterm and term infants. Br J Nutr. https:\/\/doi.org\/10.1017\/S0007114524003362","journal-title":"Br J Nutr"},{"key":"6522_CR42","doi-asserted-by":"publisher","first-page":"e2049","DOI":"10.1016\/S2214-109X(24)00380-2","volume":"12","author":"G Mzembe","year":"2024","unstructured":"Mzembe G, Moya E, Mwangi MN et al (2024) Postpartum maternal and infant haematological effects of second-trimester ferric carboxymaltose versus standard-of-care oral iron in Malawi: longitudinal follow-up of a randomised controlled trial. Lancet Glob Health 12:e2049\u2013e2058","journal-title":"Lancet Glob Health"},{"key":"6522_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/nu13072221","volume":"13","author":"HG Quezada-Pinedo","year":"2021","unstructured":"Quezada-Pinedo HG, Cassel F, Duijts L et al (2021) Maternal iron status in pregnancy and child health outcomes after birth: a systematic review and meta-analysis. Nutrients 13:2221","journal-title":"Nutrients"},{"key":"6522_CR44","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1067\/mpd.2002.121931","volume":"140","author":"RE Fleming","year":"2002","unstructured":"Fleming RE (2002) Cord serum ferritin levels, fetal iron status, and neurodevelopmental outcomes: correlations and confounding variables. J Pediatr 140:145\u2013148","journal-title":"J Pediatr"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06522-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06522-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06522-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T07:35:32Z","timestamp":1762846532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06522-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":44,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["6522"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06522-w","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"684"}}